Observational Study of the Effect of Pirfenidone on Cough in Patients With Idiopathic Pulmonary Fibrosis

Trial Profile

Observational Study of the Effect of Pirfenidone on Cough in Patients With Idiopathic Pulmonary Fibrosis

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Dec 2016

At a glance

  • Drugs Pirfenidone (Primary)
  • Indications Pulmonary fibrosis
  • Focus Therapeutic Use
  • Acronyms Cough-IPF
  • Most Recent Events

    • 21 Dec 2016 Status changed from active, no longer recruiting to completed.
    • 29 Oct 2016 Planned End Date changed from 1 Oct 2016 to 1 Nov 2016.
    • 29 Oct 2016 Planned primary completion date changed from 1 May 2016 to 1 Oct 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top